BIO Financial Facts

Net income including noncontrolling interests: 30.72M
Interest expense: 7.02M
See Full Income Statement

Total liabilities: -2.79B
Total liabilities and stockholders' equity: 3.39B
See Full Balance Sheet

Bio-Rad Laboratories, Inc. (BIO) Earnings

  |   Expand Research on BIO
Next EPS Date 8/6/14 *Est. EPS Growth Rate -66.2% *Last Qtr.
Average EPS % Beat Rate -49.1% Revenue Growth Rate +1.9% *Last Qtr.
Average % Move 1-Wk after EPS -1.8% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/6/14 Q114 $0.23$0.80 -$0.57$509M$515M N/A Details
2/27/14 Q413 $1.51$1.42 +$0.09$602.6M$586.67M N/A Details
11/7/13 Q313 -$0.25$0.91 -$1.16$505.07M$529.02M N/A Details
8/6/13 Q213 $1.20$1.25 -$0.05$525.3M$532.6M N/A Details
5/7/13 Q113 $0.68$1.06 -$0.38$499.7M$506.34M N/A Details
2/26/13 Q412 $1.65$1.34 +$0.31$573.8M$558.68M N/A Details
11/7/12 Q312 $1.48$1.17 +$0.31$498.7M$506.14M N/A Details
8/7/12 Q212 $1.69$1.19 +$0.50$510.4M$526.16M N/A Details